Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Antibody persistence 5 years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with β-thalassemia: assessing the need for booster.

Papadatou I, Lagousi T, Kattamis A, Spoulou V.

Ann Hematol. 2019 Mar;98(3):775-779. doi: 10.1007/s00277-019-03615-z. Epub 2019 Jan 25.

PMID:
30683996
2.

Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens.

Lagousi T, Basdeki P, Routsias J, Spoulou V.

Vaccines (Basel). 2019 Jan 19;7(1). pii: E9. doi: 10.3390/vaccines7010009. Review.

3.

Implementing Universal Varicella Vaccination in Europe: The Path Forward.

Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T.

Pediatr Infect Dis J. 2019 Feb;38(2):181-188. doi: 10.1097/INF.0000000000002233.

PMID:
30408002
4.

Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations.

Falup-Pecurariu OG, Diez-Domingo J, Esposito S, Finn A, Rodrigues F, Spoulou V, Syrogiannopoulos GA, Usonis V, Greenberg D; CAP-PRI.

Eur J Pediatr. 2018 Jul;177(7):1111-1120. doi: 10.1007/s00431-018-3165-3. Epub 2018 May 11.

PMID:
29748750
5.

Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.

Farmaki PF, Chini MC, Mangafas NM, Tzanoudaki MT, Piperi CP, Lazanas MZ, Spoulou VS.

J Infect Dis. 2018 Jun 5;218(1):26-34. doi: 10.1093/infdis/jiy135.

PMID:
29722823
6.

Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.

European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord, Judd A, Chappell E, Turkova A, Le Coeur S, Noguera-Julian A, Goetghebuer T, Doerholt K, Galli L, Pajkrt D, Marques L, Collins IJ, Gibb DM, González Tome MI, Navarro M, Warszawski J, Königs C, Spoulou V, Prata F, Chiappini E, Naver L, Giaquinto C, Thorne C, Marczynska M, Okhonskaia L, Posfay-Barbe K, Ounchanum P, Techakunakorn P, Kiseleva G, Malyuta R, Volokha A, Ene L, Goodall R.

PLoS Med. 2018 Jan 30;15(1):e1002491. doi: 10.1371/journal.pmed.1002491. eCollection 2018 Jan.

7.

Evaluation of Protective Efficacy of Selected Immunodominant B-Cell Epitopes within Virulent Surface Proteins of Streptococcus pneumoniae.

Papastamatiou T, Routsias JG, Koutsoni O, Dotsika E, Tsakris A, Spoulou V.

Infect Immun. 2018 Feb 20;86(3). pii: e00673-17. doi: 10.1128/IAI.00673-17. Print 2018 Mar.

8.

Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation.

Bamford A, Manno EC, Mellado MJ, Spoulou V, Marques L, Scherpbier HJ, Niehues T, Oldakowska A, Rossi P, Palma P; PENTA-vac Group.

Vaccine. 2016 Nov 4;34(46):5587-5594. doi: 10.1016/j.vaccine.2016.09.035. Epub 2016 Oct 7.

PMID:
27727030
9.

Time trends in pediatric hospitalizations for hepatitis A in Greece (1999-2013): Assessment of the impact of universal infant immunization in 2008.

Papaevangelou V, Alexopoulou Z, Hadjichristodoulou C, Kourlamba G, Katsioulis A, Theodoridou K, Spoulou V, Theodoridou M.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1852-6. doi: 10.1080/21645515.2016.1151589. Epub 2016 May 4.

10.

Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines.

Usonis V, Ivaskevicius R, Diez-Domingo J, Esposito S, Falup-Pecurariu OG, Finn A, Rodrigues F, Spoulou V, Syrogiannopoulos GA, Greenberg D; CAP-PRI Working Group.

Pneumonia (Nathan). 2016 May 2;8:5. doi: 10.1186/s41479-016-0005-y. eCollection 2016.

11.

Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?

Papadatou I, Spoulou V.

Clin Vaccine Immunol. 2016 May 6;23(5):388-395. doi: 10.1128/CVI.00721-15. Print 2016 May. Review.

12.

Perioperative antimicrobial prophylaxis in pediatric patients in Greece: Compliance with guidelines and impact of an educational intervention.

Dimopoulou A, Kourlaba G, Psarris A, Coffin S, Spoulou V, Zaoutis T.

J Pediatr Surg. 2016 Aug;51(8):1307-11. doi: 10.1016/j.jpedsurg.2015.11.017. Epub 2015 Dec 1.

PMID:
26711690
13.

Epidemiology of Community-Acquired Pneumonia Hospitalizations and Associated Complications Before and After the Implementation of the Heptavalent Pneumococcal Conjugate Vaccine in Athens, Greece.

Lagousi T, Papadatou I, Kopsidas I, Critselis E, Theodoridou M, Spoulou V.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):260-3. doi: 10.1093/jpids/pit088. Epub 2014 Jan 15.

PMID:
26407430
14.

Discovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal Disease.

Lagousi T, Routsias J, Piperi C, Tsakris A, Chrousos G, Theodoridou M, Spoulou V.

J Biol Chem. 2015 Nov 13;290(46):27500-10. doi: 10.1074/jbc.M115.666818. Epub 2015 Sep 22.

15.

Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship.

Noni M, Katelari A, Dimopoulos G, Doudounakis SE, Tzoumaka-Bakoula C, Spoulou V.

Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2235-41. doi: 10.1007/s10096-015-2474-y. Epub 2015 Aug 30.

PMID:
26319147
16.

Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPV23) in asplenic patients with β-thalassemia major.

Papadatou I, Orthopoulos G, Theodoridou M, Spoulou V.

Vaccine. 2015 Jul 31;33(32):3779-83. doi: 10.1016/j.vaccine.2015.06.100. Epub 2015 Jul 2.

PMID:
26144903
17.

Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosis.

Noni M, Katelari A, Dimopoulos G, Kourlaba G, Spoulou V, Alexandrou-Athanassoulis H, Doudounakis SE, Tzoumaka-Bakoula C.

Med Mycol. 2014 Oct;52(7):715-22. doi: 10.1093/mmy/myu038. Epub 2014 Jul 23.

PMID:
25056962
18.

Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with β-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine.

Papadatou I, Piperi C, Alexandraki K, Kattamis A, Theodoridou M, Spoulou V.

Clin Infect Dis. 2014 Sep 15;59(6):862-5. doi: 10.1093/cid/ciu409. Epub 2014 May 30.

PMID:
24879786
19.

Rotavirus vaccination in Europe: drivers and barriers.

Parez N, Giaquinto C, Du Roure C, Martinon-Torres F, Spoulou V, Van Damme P, Vesikari T.

Lancet Infect Dis. 2014 May;14(5):416-25. doi: 10.1016/S1473-3099(14)70035-0. Review.

PMID:
24758998
20.

Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.

Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI.

Vaccine. 2014 Mar 10;32(12):1394-7. doi: 10.1016/j.vaccine.2013.11.106. Epub 2014 Jan 30.

PMID:
24486348
21.

Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.

Theodoridou K, Margeli A, Spoulou V, Bathrellou I, Skevaki C, Chrousos GP, Papassotiriou I, Kanaka-Gantenbein C.

Scand J Clin Lab Invest. 2014 Jan;74(1):67-73. doi: 10.3109/00365513.2013.859725. Epub 2013 Nov 22.

PMID:
24266781
22.

Current epidemiology of childhood tuberculous meningitis in Greece: a 10-year population-based study.

Rallis D, Spoulou V, Theodoridou M, Critselis E, Michailidou E, Kavaliotis J, Roilides E, Katragou A, Galanakis E, Triga M, Krokidas G, Tzoufi M, Spala G, Dikaiakou E, Paraskakis E, Syrogiannopoulos G, Papaventsis D, Tsolia MN.

Int J Tuberc Lung Dis. 2013 Jun;17(6):847-8. doi: 10.5588/ijtld.13.0002. No abstract available.

PMID:
23676174
23.

Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact?

Zellos A, Spoulou V, Roma-Giannikou E, Karentzou O, Dalekos GN, Theodoridou M.

Ann Hepatol. 2013 Jan-Feb;12(1):147-51.

24.

Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat?

Esposito S, Cohen R, Domingo JD, Pecurariu OF, Greenberg D, Heininger U, Knuf M, Lutsar I, Principi N, Rodrigues F, Sharland M, Spoulou V, Syrogiannopoulos GA, Usonis V, Vergison A, Schaad UB.

Pediatr Infect Dis J. 2012 Jun;31(6):e78-85. doi: 10.1097/INF.0b013e318255dc5b. Review.

PMID:
22466326
25.

Complicated pneumococcal meningitis in a fully vaccinated child: value of magnetic resonance imaging monitoring.

Ilia S, Spanaki AM, Raissaki M, Spoulou VI, Fitrolaki MD, Kanariou M, Tzanakaki G, Briassoulis G.

Neuropediatrics. 2011 Dec;42(6):240-4. doi: 10.1055/s-0031-1295407. Epub 2011 Nov 14.

PMID:
22083882
26.

Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.

Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI.

Vaccine. 2011 Sep 16;29(40):6834-7. doi: 10.1016/j.vaccine.2011.07.053. Epub 2011 Jul 29.

PMID:
21803106
27.

Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.

Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, Mast TC, Staat MA.

Hum Vaccin. 2011 Jul;7(7):734-48. doi: 10.4161/hv.7.7.15511. Epub 2011 Jul 1. Review.

PMID:
21734466
28.

Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy.

Spoulou V, Kanaka-Gantenbein C, Bathrellou I, Mora S, Mostrou G, Sidossis L, Chrousos G, Theodoridou M.

Hormones (Athens). 2011 Apr-Jun;10(2):149-55.

29.

Natural and vaccine-induced immunity to Neisseria meningitidis serogroup C in asplenic patients with β-thalassemia.

Spoulou V, Tzanakaki G, Lekka S, Chouliaras G, Ladis V, Theodoridou M.

Vaccine. 2011 Jun 15;29(27):4435-8. doi: 10.1016/j.vaccine.2011.03.080. Epub 2011 Apr 15.

PMID:
21497638
30.

Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study.

Thomaidis L, Bertou G, Critselis E, Spoulou V, Kafetzis DA, Theodoridou M.

BMC Pediatr. 2010 Dec 27;10:99. doi: 10.1186/1471-2431-10-99.

31.

A 2-year-old girl with fever, abdominal pain, and lung cavities.

Vasilopoulou V, Makris A, Mostrou G, Spoulou V, Syriopoulou V, Theodoridou M.

Pediatr Infect Dis J. 2010 Nov;29(11):1061, 1065-6. No abstract available.

PMID:
21046702
32.

The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis.

Farmaki E, Kanakoudi-Tsakalidou F, Spoulou V, Trachana M, Pratsidou-Gertsi P, Tritsoni M, Theodoridou M.

Vaccine. 2010 Jul 12;28(31):5109-13. doi: 10.1016/j.vaccine.2010.03.080. Epub 2010 May 12.

PMID:
20470802
33.

Vaccine-associated herpes zoster ophthalmicus [correction of opthalmicus] and encephalitis in an immunocompetent child.

Chouliaras G, Spoulou V, Quinlivan M, Breuer J, Theodoridou M.

Pediatrics. 2010 Apr;125(4):e969-72. doi: 10.1542/peds.2009-2633. Epub 2010 Mar 1.

PMID:
20194287
34.

Ascariasis in an adolescent with AIDS.

Roma-Giannikou E, Viazis N, Spoulou V, Theodoridou M.

J Pediatr Gastroenterol Nutr. 2009 Jan;48(1):1. doi: 10.1097/MPG.0b013e31819144f2. No abstract available.

PMID:
19172116
35.

The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia.

Orthopoulos GV, Theodoridou MC, Ladis VA, Tsousis DK, Spoulou VI.

Vaccine. 2009 Jan 14;27(3):350-4. doi: 10.1016/j.vaccine.2008.10.070. Epub 2008 Nov 14.

PMID:
19010369
36.

Objective analysis of retinal function in HIV-positive children without retinitis using optical coherence tomography.

Moschos MM, Mostrou G, Psimenidou E, Spoulou V, Theodoridou M.

Ocul Immunol Inflamm. 2007 Jul-Aug;15(4):319-23.

PMID:
17763130
37.

Conjugate vaccine-induced immunological priming is not protective against acute meningococcal C infection.

Spoulou VI, Moschou CK, Tzanakaki G, Theodoridou MC.

Vaccine. 2007 Oct 10;25(41):7012-3. Epub 2007 Aug 1. No abstract available.

PMID:
17707961
38.

Natural and vaccine-induced immunity against Haemophilus influenzae type b in patients with beta-thalassemia.

Spoulou VI, Tsoumas DL, Ladis V, Spentzou A, Theodoridou MC.

Vaccine. 2006 Apr 12;24(16):3050-3. Epub 2006 Jan 30.

PMID:
16519975
39.

Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children.

Spoulou VI, Tsoumas DL, Papaevangelou VG, Mostrou GI, Theodoridou MC.

Vaccine. 2005 Nov 16;23(46-47):5289-93. Epub 2005 Jun 21.

PMID:
16054732
40.

Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.

Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S.

Bone Marrow Transplant. 2004 Jun;33(12):1187-90.

PMID:
15077129
41.

Haemophilus influenzae type b conjugate vaccine-induced immunological memory in symptomatic HIV-1-infected children.

Spoulou VI, Tsoumas DL, Papaevangelou VG, Mostrou GI, Theodoridou MC.

AIDS. 2003 Jun 13;17(9):1396-8. No abstract available.

PMID:
12799564
42.

Protein conjugate pneumococcal vaccines.

Spoulou V, Gilks CF, Ioannidis JP.

BMJ. 2002 Mar 30;324(7340):750-1. No abstract available. Erratum in: BMJ 2002 Apr 27;324(7344):1002.

43.

23-valent pneumococcal vaccination and HIV.

Spoulou V, Theodoridou M, Papaevangelou VG, Mostrou GI, Ioannidis JP.

Lancet. 2000 Sep 16;356(9234):1027-8. No abstract available.

PMID:
11041419
44.

Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants.

Spoulou V, Victoratos P, Ioannidis JP, Grafakos S.

J Infect Dis. 2000 Sep;182(3):965-9. Epub 2000 Aug 3.

PMID:
10950799
45.

Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection.

Gibb D, Giacomelli A, Masters J, Spoulou V, Ruga E, Griffiths H, Kroll S, Giaquinto C, Goldblatt D.

Pediatr Infect Dis J. 1996 Dec;15(12):1097-101.

PMID:
8970219
46.

Hypogammaglobulinaemia secondary to reflux oesophagitis.

Spoulou V, Melville C, Young M, Milla P, Newman C, Morgan G.

Arch Dis Child. 1995 Mar;72(3):245-6.

47.

Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection.

Gibb D, Spoülou V, Giacomelli A, Griffiths H, Masters J, Misbah S, Nokes L, Pagliaro A, Giaquinto C, Kroll S, et al.

Pediatr Infect Dis J. 1995 Feb;14(2):129-35.

PMID:
7746695

Supplemental Content

Loading ...
Support Center